AML suppresses hematopoiesis by releasing exosomes that contain microRNAs targeting c-MYB

Area of Science:

• Cancer Biology
• Hematopoiesis
• Extracellular Vesicles

Background:

• Exosomes regulate the tumor microenvironment and carry diverse cargo.
• Acute myeloid leukemia (AML) exosomes can suppress hematopoietic stem and progenitor cell (HSPC) function.
• AML exosome-mediated miRNA trafficking contributes to systemic hematopoietic dysfunction.

Purpose of the Study:

• To investigate the direct impact of AML exosomes on HSPC function.
• To identify specific microRNAs (miRNAs) within AML exosomes responsible for HSPC suppression.
• To elucidate the molecular mechanisms underlying AML exosome-mediated hematopoiesis impairment.

Main Methods:

• Isolation and characterization of exosomes from AML cells and plasma.
• Co-culture of HSPCs with AML exosomes.
• Quantification of miRNA enrichment (miR-150, miR-155) in exosomes.
• Assessment of HSPC clonogenicity and c-MYB translation suppression.
• RNA-induced silencing complex (RISC)-trap coimmunoprecipitation and high-throughput sequencing for miRNA target identification.
• Integration of miRNA targets with protein-protein interaction data (STRING).

Main Results:

• AML exosomes, particularly those enriched in miR-150 and miR-155, impair HSPC clonogenicity.
• miR-150 and miR-155 directly suppress c-MYB translation in HSPCs, affecting differentiation and proliferation.
• Novel miR-155 targets and indirectly affected proteins were identified.
• AML exosomes exert a direct, stroma-independent suppressive effect on hematopoiesis.

Conclusions:

• AML exosomes directly compromise HSPC function via miRNA-mediated c-MYB suppression.
• This mechanism contributes to the loss of hematopoietic function in AML.
• Combining miRNA target and protein-protein interaction data is a valuable strategy for understanding exosome-mediated effects in the tumor microenvironment.